Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.0 - $76.01 $0 - $316 Million
-4,157,552 Closed
0 $0
Q2 2022

Aug 12, 2022

BUY
$24.32 - $75.3 $5.94 Million - $18.4 Million
244,424 Added 6.25%
4,157,552 $313 Million
Q1 2022

May 13, 2022

BUY
$24.73 - $51.25 $885,061 - $1.83 Million
35,789 Added 0.92%
3,913,128 $105 Million
Q4 2021

Feb 14, 2022

BUY
$35.48 - $67.33 $354,870 - $673,434
10,002 Added 0.26%
3,877,339 $185 Million
Q3 2021

Nov 12, 2021

BUY
$61.0 - $81.99 $10.1 Million - $13.6 Million
165,770 Added 4.48%
3,867,337 $257 Million
Q2 2021

Aug 13, 2021

BUY
$62.93 - $90.59 $233 Million - $335 Million
3,701,567 New
3,701,567 $289 Million

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.